All In Biotech

Drug Trial Radar · NCT06095115

A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Retreatment

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 684 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

684

Actual

Start

Oct 12, 2023

Primary completion

Jul 29, 2024

Study completion Apr 6, 2027

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Oct 23, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.

Conditions

  • Plaque Psoriasis

Interventions

  • JNJ-77242113Drug

    JNJ-77242113 will be administered orally.

  • PlaceboDrug

    Placebo will be administered orally

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Achieved an Investigator's Global Assessment (IGA) Score of 0 or 1 and Greater Than or Equal to (>=) 2-Grade Improvement From Baseline at Week 16Time frame: Week 16
  2. Percentage of Participants Who Achieved Psoriasis Area and Severity Index (PASI) 90 Response at Week 16Time frame: Week 16

Locations

170 sites in 16 countries. Site status is shown where the registry gives one.

  • Medical Dermatology Specialists

    Phoenix, Arizona

  • Johnson Dermatology

    Fort Smith, Arkansas

  • First OC Dermatology

    Fountain Valley, California

  • Center for Dermatology Clinical Research

    Fremont, California

  • Integrative Skin Science and Research

    Sacramento, California

  • Rady Childrens Hospital San Diego

    San Diego, California

  • Southern California Dermatology

    Santa Ana, California

  • Clinical Science Institute

    Santa Monica, California

  • Bioclinical Research Alliance Inc.

    Miami, Florida

  • Ziaderm Research LLC

    North Miami Beach, Florida

  • Forcare Clinical Research Inc

    Tampa, Florida

  • Skin Care Physicians of Georgia

    Macon, Georgia

  • Arlington Dermatology

    Rolling Meadows, Illinois

  • Endeavor Health

    Skokie, Illinois

  • Dundee Dermatology

    West Dundee, Illinois

  • Dawes Fretzin Clinical Research Group LLC

    Indianapolis, Indiana

  • Indiana Clinical Trial Center

    Plainfield, Indiana

  • Qualmedica Research

    Owensboro, Kentucky

  • Dermatology and Advanced Aesthetics

    Lake Charles, Louisiana

  • Allcutis Research 1

    Beverly, Massachusetts

  • Michigan Center of Medical Research

    Clarkston, Michigan

  • Minnesota Clinical Study Center

    New Brighton, Minnesota

  • Skin Specialists

    Omaha, Nebraska

  • Allcutis Research

    Portsmouth, New Hampshire

  • Schweiger Dermatology Group

    East Windsor, New Jersey

  • Icahn School of Medicine at Mt. Sinai

    New York, New York

  • Wilmington Dermatology Center

    Wilmington, North Carolina

  • Oakview Dermatology

    Athens, Ohio

  • Optima Research

    Boardman, Ohio

  • Pharmacology Translational Unit PTU Fairborn LLC

    Fairborn, Ohio

  • Central Sooner Research

    Oklahoma City, Oklahoma

  • Oregon Medical Research Center

    Portland, Oregon

  • Oregon Dermatology and Research Center

    Portland, Oregon

  • The Pennsylvania Centre for Dermatology, LLC

    Exton, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

  • Health Concepts

    Rapid City, South Dakota

  • Arlington Research Center, Inc.

    Arlington, Texas

  • The University of Texas Health Science Center at Houston

    Bellaire, Texas

  • Center for Clinical Studies 1

    Houston, Texas

Showing 40 of 170 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.